Arkolith/Insider Trading/GALT/Form 4

Lewis Joel

President and CEO, DirectorGALECTIN THERAPEUTICS INC (GALT) · full profile →Form 4 · filed Jan 13, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 5, 2026disposed()56K$3.88$219K776K

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001133416-26-000010) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML